Shan Lu mainly investigates Virology, DNA vaccination, Virus, Neutralizing antibody and Antibody. His Virology study combines topics in areas such as Immunology, Immunoglobulin G, Immune system and Antigen. His Antigen research includes themes of HIV vaccine and Heterologous.
The study incorporates disciplines such as Immunity, Immunogenicity, Microbiology, Viral Vaccine and Simian immunodeficiency virus in addition to DNA vaccination. Within one scientific family, Shan Lu focuses on topics pertaining to Gene gun under Virus, and may sometimes address concerns connected to Electroporation. His Neutralizing antibody research incorporates elements of Titer, Neutralization and Recombinant DNA.
His primary areas of study are Virology, Antibody, Immunology, DNA vaccination and Antigen. Shan Lu has included themes like Immune system and Immunogenicity in his Virology study. Shan Lu works mostly in the field of Antibody, limiting it down to concerns involving Recombinant DNA and, occasionally, Priming.
He has researched Immunology in several fields, including Viral vector and AIDS Vaccines. As a member of one scientific family, Shan Lu mostly works in the field of DNA vaccination, focusing on Microbiology and, on occasion, Yersinia pestis and Hemagglutination assay. His research integrates issues of Heterologous, HIV vaccine and Immunization in his study of Vaccination.
Shan Lu spends much of his time researching Virology, Antibody, Immunology, Vaccination and DNA vaccination. His Virology research is mostly focused on the topic Neutralization. His studies in Antibody integrate themes in fields like Protein structure, HIV vaccine and Glycoprotein.
His work in Immunology covers topics such as DNA which are related to areas like Neutralizing antibody, Innate immune system and Antigen. His Vaccination research is multidisciplinary, incorporating perspectives in Gene, Hiv 1 envelope and B cell. His Immune system research incorporates elements of Virus and Binding site.
His primary areas of investigation include Virology, Antibody, Monoclonal antibody, Immunogenicity and Immunology. His work on Virology is being expanded to include thematically relevant topics such as Healthy individuals. His Antibody study integrates concerns from other disciplines, such as Protein structure and Accessible surface area.
His study in Monoclonal antibody is interdisciplinary in nature, drawing from both Pathogen, Immunization, Recombinant DNA and Dna immunization. His study on Immunogenicity is covered under Antigen. His research brings together the fields of Interleukin 12 and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.
H L Robinson;D C Montefiori;R P Johnson;K H Manson.
Nature Medicine (1999)
Heterologous prime-boost vaccination.
Current Opinion in Immunology (2009)
The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region
S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis.
Journal of Virology (2001)
Simian immunodeficiency virus DNA vaccine trial in macaques.
Shan Lu;James Arthos;David C. Montefiori;Yasuhiro Yasutomi.
Journal of Virology (1996)
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
Shixia Wang;Jeffrey S. Kennedy;Kim West;David C. Montefiori.
Use of DNAs Expressing HIV-1 Env and Noninfectious HIV-1 Particles to Raise Antibody Responses in Mice
Shan Lu;Joseph C. Santoro;Deborah H. Fuller;Joel R. Haynes.
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.
Yasuhiro Yasutomi;Harriet L. Robinson;Shan Lu;Farah Mustafa.
Journal of Virology (1996)
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
Shixia Wang;Ranajit Pal;John R. Mascola;Te-Hui W. Chou.
EV71: An emerging infectious disease vaccine target in the Far East?
Juan Xu;Yuan Qian;Shixia Wang;Shixia Wang;Jill M. Grimes Serrano.
Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines
Shixia Wang;Jessica Taaffe;Christopher S. Parker;Alicia Solorzano.
Journal of Virology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: